Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 321 | BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | 35,709.0 | $253K | 0.07% | NEW | — | $7.08 | -38.6% |
| 322 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 45,946.0 | $253K | 0.07% | NEW | — | $5.50 | -0.9% |
| 323 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 7,174.0 | $252K | 0.07% | NEW | — | $35.18 | -18.4% |
| 324 | CELC | CELCUITY INC | Healthcare | 2,528.0 | $252K | 0.07% | NEW | — | $99.74 | +31.3% |
| 325 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 28,452.0 | $252K | 0.07% | NEW | — | $8.86 | +132.8% |
| 326 | KROS | KEROS THERAPEUTICS INC | Healthcare | 12,367.0 | $252K | 0.07% | NEW | — | $20.36 | -50.1% |
| 327 | ABCL | ABCELLERA BIOLOGICS INC | Healthcare | 73,488.0 | $251K | 0.07% | NEW | — | $3.42 | +18.4% |
| 328 | RXRX | RECURSION PHARMACEUTICALS IN | Healthcare | 61,439.0 | $251K | 0.07% | NEW | — | $4.09 | -29.3% |
| 329 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 10,034.0 | $251K | 0.07% | NEW | — | $25.01 | +58.7% |
| 330 | ARVN | ARVINAS INC | Healthcare | 21,148.0 | $251K | 0.07% | NEW | — | $11.86 | -27.9% |
| 331 | — | ASSEMBLY BIOSCIENCES INC | — | 7,369.0 | $251K | 0.07% | NEW | — | $34.01 | — |
| 332 | — | NEWAMSTERDAM PHARMA COMPANY | — | 7,142.0 | $251K | 0.07% | NEW | — | $35.08 | — |
| 333 | IRWD | IRONWOOD PHARMACEUTICALS INC | Healthcare | 74,311.0 | $250K | 0.07% | NEW | — | $3.37 | +3.9% |
| 334 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 5,676.0 | $250K | 0.07% | NEW | — | $44.05 | +7.6% |
| 335 | XNCR | XENCOR INC | Healthcare | 16,103.0 | $247K | 0.07% | NEW | — | $15.31 | -27.8% |
| 336 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 20,307.0 | $245K | 0.07% | NEW | — | $12.08 | +5.5% |
| 337 | PRTA | PROTHENA CORP PLC | Healthcare | 25,679.0 | $245K | 0.07% | NEW | — | $9.55 | +0.4% |
| 338 | — | RAPT THERAPEUTICS INC | — | 7,229.0 | $245K | 0.07% | NEW | — | $33.87 | — |
| 339 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 31,783.0 | $245K | 0.07% | NEW | — | $7.70 | +58.6% |
| 340 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 14,795.0 | $244K | 0.07% | NEW | — | $16.51 | +11.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
25.9%
Financial Services
25.7%
Technology
17.4%
Industrials
10.0%
Consumer Cyclical
7.5%
Communication Services
4.3%
Energy
2.6%
Real Estate
2.5%
Consumer Defensive
1.8%
Basic Materials
1.5%